Supra Inguinal Fascia Iliaca Block as Rescue Analgesia Following Total Hip Arthroplasty

Launched by INSTITUT MUTUALISTE MONTSOURIS · May 18, 2025

Keywords

ClinConnect Summary

This clinical trial is studying a new way to manage pain after hip replacement surgery, specifically using a technique called the Supra-Inguinal Fascia Iliaca Block (SIFIB). This nerve block aims to help patients who experience significant pain after their surgery by numbing the nerves around the hip. While hip replacement surgery is generally manageable in terms of pain, some patients may face severe discomfort, which could require high doses of pain medication. The goal of the trial is to see if giving this nerve block only to those who are in considerable pain can help them recover better and walk more easily.

To participate in the trial, patients need to be scheduled for a hip replacement surgery and provide written consent. However, those who have complications during surgery that prevent them from walking or who do not experience significant pain afterward will not be included. Participants can expect to receive the SIFIB if they're in pain after the surgery, and the study will focus on how well this approach works in relieving pain and improving mobility. It's important to note that the trial does not involve any new medications, as it uses a local anesthetic that is commonly used in other procedures.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • patient scheduled for a primary total hip arthroplasty under general anesthesia,
• • written informed consent.
• Exclusion Criteria:
• • per-operative complication making wheight-bearing and walking contra-indicated.
• • patient without significant pain post-operatively.